Stop MS Appeal Board
I am personally dedicated to this important cause and excited about the possibilities that lie ahead. Our aim is to raise £100 million for medical research to transform the wellbeing, outlook and quality of life for everyone affected by MS. With your help we can make medical history. Together we can stop MS. Sir Vernon Ellis
Stop MS Board members
Sir Vernon Ellis
Sir Vernon Ellis is a former Chairman of the British Council, the UK’s International Cultural Relations Organisation. Before that he was at Accenture for 40 years where he was International Chairman.
He is President of the English National Opera and supports a range of arts organisations through his own organisation. He was knighted in 2011 for services to music and in 2012 was appointed Chairman of the Arts and Media Honours Committee.
Kate Hely-Hutchinson runs her own company, the DD Bag Company, manufacturing bespoke bags and seating.
Kate used to work in corporate finance at Nomura International covering major UK businesses and banks, in bond finance and equity-related deals. Kate's husband Nick has progressive MS. She was Chair of the Steering Group that developed the vision for our Stop MS Appeal Board and has co-hosted many of our events.
Sir David Bell
Board member and Chairman of Stop MS Pioneers
Knighted for his longstanding services to industry, the arts and charity, Sir David Bell is a non-executive director of The Economist, former Chair and Chief Executive of the Financial Times.
Sir David was Chair of homelessness charity, Crisis for 10 years. He also chairs Cambridge University Press, Roehampton University and Coram, a national charity focused on better chances for children since 1739.
Donald Cameron of Lochiel
Donald Cameron of Lochiel trained as a chartered accountant, and is a former Director of J. Henry Schroder Wagg.
He's served as a 2nd Lieutenant in the Queen’s Own Cameron Highlanders, President of the Highland Society of London, Justice of the Peace (JP) of the Highland Region and Deputy Lord-Lieutenant of Inverness. In 2002 he became Lord-Lieutenant of Inverness.
Iain is the Group Chief Executive of Centrica plc. Before that he was a Board member of BP for 10 years from 2004. He also served as a non-executive director and senior independent director of Rolls-Royce Holdings plc.
He's a non-executive director of BT Group plc, Chairman of the Advisory Board of Imperial College Business School and a Trustee of Movement to Work.
Josh Krichefski is Chief Executive of MediaCom UK, the most successful media and communications agency in the country.
MediaCom manages accounts for some of the country's smartest advertisers including Sky, Volkswagen and Universal. Josh is responsible for overseeing digital growth, new business and marketing and product development. Before joining MediaCom, he was a Global Director at Havas Digital.
Nick Maclean is a founder director of Eykyn Maclean, a private art gallery based in New York and London.
Nick started his career with Christie’s, working in London as a specialist in 19th century European paintings. He moved to New York to become co-head of Christie’s impressionist and modern art department with Christopher Eykyn. As well as building art collections around the world, they've held several museum quality exhibitions on artists like Van Gogh, Giacometti and Warhol.
Sir Peter Middleton
Sir Peter Middleton is Chairman of Burford Capital, Hamilton Ventures and Hume Capital Securities Ltd.
He was previously Chairman of Camelot Group plc, and a Director, Chairman and Deputy Chairman of United Utilities. Sir Peter was a Chancellor of Sheffield University, a senior adviser of Fenchurch Advisory Partners and a Trustee of the Philharmonia Orchestra. He spent nearly 30 years at HM Treasury and was Permanent Secretary from 1983 to 1991.
Sir Geoffrey Owen
Sir Geoffrey has spent most of his career as a journalist with the Financial Times, serving as editor from 1981 to 1990.
He's also worked for British Leyland Motor Corporation and was Senior Fellow at the London School of Economics. His books include ‘From Empire to Europe: the decline and revival of British industry since the Second World War', and ‘The rise and fall of great companies: Courtaulds and the reshaping of the man-made fibres industry’.
Professor Alan Thompson MD
Professor Alan Thompson is Dean of the Faculty of Brain Sciences at University College London and Chair of the UCL Partners Academic Health Science Centre Neuroscience Programme.
His main area of expertise is in demyelinating disease, particularly diagnosis, evaluation, and management of MS, focusing on the pathological mechanisms that underpin neurological disability and recovery using structural and functional imaging.
Sir David Walker
Sir David Walker is non-Executive Chairman of Winton Capital Management.
Previously, he was Chairman of Barclays and CEO of Morgan Stanley International. Sir David began his career at HM Treasury and the Bank of England. He was a non executive member of the Court of the Bank of England. He's also an emeritus member of the Group of 30 (G30) and was Chairman of the Business Leaders’ Group of East End charity, Community Links.
Ex-officio Board member
Nick Winser is our Chair of Trustees.
Nick's wife, Denise, was diagnosed with MS in 1999. He's witnessed many of the challenges that come with MS, including with progression and getting access to effective treatments. Nick's career has been devoted to the energy sector. Formerly European CEO of the National Grid, he's now Chairman of UK Government initiative Energy Systems Catapult and sits on the board of Mid Warwickshire Mencap.
CEO, MS Society
Nick became our CEO early in 2019.
He brings with him a wealth of experience in leadership and the health sector, with a really strong background in the NHS. His last two roles have been as CEO, most recently at King's College Hospital NHS Foundation Trust where he had overall responsibility for leading one of the biggest specialist Neurosciences services nationally. Before that he was CEO at Royal Surrey County Hospital NHS Foundation Trust for nine years.
Dr Susan Kohlhaas
Executive Board member
Susan is our Executive Director of Research.
She worked as the Head of Strategy and Initiatives at the National Cancer Research Institute where she developed their five year organisational strategy. She had previously worked with us for 7 years holding various senior roles including Head of Biomedical Research. Susan holds a PhD in cancer biology from the University of Leicester and was a Postdoctoral Researcher at the Babraham Institute in Cambridge working in immunology.
Dr Emma Whitcombe
Executive Board member
Emma is our Executive Director of Fundraising.
She was previously Director of Senior Relationships at the National Autistic Society, and held senior fundraising roles at Save the Children, Cystic Fibrosis Trust and Marie Curie Cancer Care. Emma has developed and led award-winning major gift programmes and appeals, as well as recruiting high profile Development Boards. She holds a PhD in Developmental Psychology and was a Research Fellow at the University of Sussex.